DNA-PK – a candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival

PURPOSE: Therapy resistance and associated liver disease make hepatocellular cancers (HCC) difficult to treat with traditional cytotoxic therapies, while newer targeted approaches offer only modest survival benefit. We focused on DNA-dependent protein kinase, DNA-PKcs, encoded by PRKDC and central t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cancer Res
Egile Nagusiak: Cornell, Liam, Munck, Joanne, Alsinet, Clara, Villanueva, Augusto, Ogle, Laura, Willoughby, Catherine, Televantou, Despina, Thomas, Huw, Jackson, Jennifer, Burt, Alastair, Newell, David, Rose, John, Manas, Derek M, Shapiro, Geoffrey, Curtin, Nicola, Reeves, Helen L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335075/
https://ncbi.nlm.nih.gov/pubmed/25480831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0842
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak